On Tuesday, Twist Bioscience Corp (NASDAQ: TWST) opened higher 6.07% from the last session, before settling in for the closing price of $29.33. Price fluctuations for TWST have ranged from $23.30 to $55.33 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 18.31% annually for the last half of the decade. Company’s average yearly earnings per share was noted -14.75% at the time writing. With a float of $57.92 million, this company’s outstanding shares have now reached $60.63 million.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Twist Bioscience Corp is 5.28%, while institutional ownership is 116.83%. The most recent insider transaction that took place on Nov 21 ’25, was worth 20,063. In this transaction an insider of this company sold 757 shares at a rate of $26.50, taking the stock ownership to the 145,402 shares. Before that another transaction happened on Nov 21 ’25, when Company’s President and COO sold 1,776 for $26.50, making the entire transaction worth $47,070. This insider now owns 332,883 shares in total.
Twist Bioscience Corp (TWST) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.53 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.63) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.66% during the next five years compared to 18.31% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Check out the current performance indicators for Twist Bioscience Corp (TWST). In the past quarter, the stock posted a quick ratio of 3.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Let’s dig in a bit further. During the last 5-days, its volume was 1.88 million. That was better than the volume of 1.36 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 73.03%.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 48.60%, which indicates a significant decrease from 88.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.07 in the past 14 days, which was higher than the 1.80 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.01, while its 200-day Moving Average is $33.64. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $32.10. Second resistance stands at $33.09. The third major resistance level sits at $34.70. If the price goes on to break the first support level at $29.50, it is likely to go to the next support level at $27.89. The third support level lies at $26.90 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are currently 61,148K shares outstanding in the company with a market cap of 1.90 billion. Presently, the company’s annual sales total 376,570 K according to its annual income of -77,670 K. Last quarter, the company’s sales amounted to 99,010 K and its income totaled -27,140 K.
